These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17310509)

  • 1. I have type 2 diabetes and my doctor regularly tests for kidney damage by checking my urine for protein. What's the connection?
    Mayo Clin Health Lett; 2006 Dec; 24(12):8. PubMed ID: 17310509
    [No Abstract]   [Full Text] [Related]  

  • 2. [Subclinical albuminuria, microalbuminuria and proteinuria--accepted cardiovascular risk markers?].
    Schmieder RE; Schrader J; Zidek W; Tebbe U; Bramlage P; Paar WD; Böhm M
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2665-71. PubMed ID: 17109277
    [No Abstract]   [Full Text] [Related]  

  • 3. On call. In your October 2010 issue you discussed blood in the urine. I don't have that problem, but during my annual checkup last week, my doctor found protein in my urine. Is it a serious problem? And what should I do about it?
    Simon HB
    Harv Mens Health Watch; 2012 Apr; 16(9):8. PubMed ID: 22928198
    [No Abstract]   [Full Text] [Related]  

  • 4. Microalbuminuria in cats.
    Langston C
    J Am Anim Hosp Assoc; 2004; 40(4):251-4. PubMed ID: 15238554
    [No Abstract]   [Full Text] [Related]  

  • 5. [Are we ready to screen for albuminuria in the general population?].
    Mangione F
    G Ital Nefrol; 2010; 27(5):445. PubMed ID: 20922673
    [No Abstract]   [Full Text] [Related]  

  • 6. [Albumin in urine--which diagnosis is now necessary?].
    MMW Fortschr Med; 2006 Sep; 148(39):20. PubMed ID: 17059190
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between urinary albumin excretion and plasma 5-hydroxyindole-3-acetic acid concentration in men with type 2 diabetes.
    Fukui M; Ose H; Hasegawa G; Yoshikawa T; Nakamura N
    Diabetes Care; 2007 Oct; 30(10):2649-51. PubMed ID: 17623827
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for the use of urinary albumin as marker of kidney involvement in unselected populations.
    McQueen MJ
    Scand J Clin Lab Invest Suppl; 2008; 241():52-6. PubMed ID: 18569965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microalbuminuria--a biomarker of renal microvascular disease.
    Futrakul N; Sridama V; Futrakul P
    Ren Fail; 2009; 31(2):140-3. PubMed ID: 19212911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to measure proteinuria?
    McIntyre NJ; Taal MW
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):600-3. PubMed ID: 18941353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased urinary concentration of Tamm-Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients.
    Sejdiu I; Torffvit O
    Scand J Urol Nephrol; 2008; 42(2):168-74. PubMed ID: 17907053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does bacteriuria interfere with albuminuria measurements of patients with diabetes?
    Kramer CK; Camargo J; Ricardo ED; Almeida FK; Canani LH; Gross JL; Azevedo MJ
    Nephrol Dial Transplant; 2009 Apr; 24(4):1193-6. PubMed ID: 19015170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring.
    Rossing K
    Dan Med Bull; 2007 May; 54(2):79-98. PubMed ID: 17521525
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteomic identification of urinary biomarkers of diabetic nephropathy.
    Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
    Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuminuria as early test for vascular disease.
    Remuzzi G; Weening JJ
    Lancet; 2005 Feb 12-18; 365(9459):556-7. PubMed ID: 15708086
    [No Abstract]   [Full Text] [Related]  

  • 16. [Microalbuminuria is a test for low molecular-weight biological impurities in the body's intercellular environment].
    Titov VN
    Klin Lab Diagn; 2007 Dec; (12):3-15. PubMed ID: 18228664
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Charlton-Menys V; DeMicco DA; Fuller JH;
    Am J Kidney Dis; 2009 Nov; 54(5):810-9. PubMed ID: 19540640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albuminuria in heart failure: a CHARMing new risk factor?
    Damman K; Hillege HL; van Veldhuisen DJ
    Lancet; 2009 Aug; 374(9689):506-8. PubMed ID: 19683628
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory issues in measuring and reporting urine albumin.
    Miller WG; Bruns DE
    Nephrol Dial Transplant; 2009 Mar; 24(3):717-8. PubMed ID: 19225022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.